Healthcare -
Biotechnology - NASDAQ - US
$ 23.46
-0.509 %
$ 3.38 B
Market Cap
-8.5
P/E
DNLI - NET INCOME
Net Income DNLI - Denali Therapeutics Inc.
-145 M
LAST VALUE
29.31%
2 YEAR CAGR
-32.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR